Cargando…

A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization

Silicosis is one of the potentially fatal occupational diseases characterized by respiratory dysfunction, chronic interstitial inflammation, and fibrosis, for which treatment options are limited. Previous studies showed that a novel N-arylpyridone compound named AKEX0011 exhibited anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Mingming, Xiao, Huijuan, Song, Dingyun, Zhu, Lili, Zhang, Jie, Zhang, Xinran, Wang, Jing, Dai, Huaping, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983992/
https://www.ncbi.nlm.nih.gov/pubmed/35401236
http://dx.doi.org/10.3389/fphar.2022.848435
_version_ 1784682081979203584
author Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
author_facet Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
author_sort Fan, Mingming
collection PubMed
description Silicosis is one of the potentially fatal occupational diseases characterized by respiratory dysfunction, chronic interstitial inflammation, and fibrosis, for which treatment options are limited. Previous studies showed that a novel N-arylpyridone compound named AKEX0011 exhibited anti-inflammatory and anti-fibrotic effects in bleomycin-induced pulmonary fibrosis; however, it is unknown whether it could also be effective against silicosis. Therefore, we sought to investigate the preventive and therapeutic roles of AKEX0011 in a silicosis rodent model and in a silica-stimulated macrophage cell line. In vivo, our results showed that AKEX0011 ameliorated silica-induced imaging lung damages, respiratory dysfunction, reduced the secretion of inflammatory and fibrotic factors (TNF-α, IL-1β, IL-6, TGF-β, IL-4, and IL-10), and the deposition of fibrosis-related proteins (collagen I, fibronectin, and α-SMA), regardless of early or advanced therapy. Specifically, we found that AKEX0011 attenuated silicosis by inhibiting apoptosis, blocking the ASK1-p38 MAPK signaling pathway, and regulating polarization of macrophages. In vitro, AKEX0011 inhibited macrophages from secreting inflammatory cytokines and inhibited apoptosis of macrophages in pre-treated and post-treated models, concurrent with blocking the ASK1-p38 pathway and inhibiting M1 polarization. Collectively, AKEX0011, as a novel N-arylpyridone compound, exerted protective effects for silica-induced pulmonary inflammation and fibrosis both in vivo and in vitro, and hence, it could be a strong drug candidate for the treatment of silicosis.
format Online
Article
Text
id pubmed-8983992
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89839922022-04-07 A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization Fan, Mingming Xiao, Huijuan Song, Dingyun Zhu, Lili Zhang, Jie Zhang, Xinran Wang, Jing Dai, Huaping Wang, Chen Front Pharmacol Pharmacology Silicosis is one of the potentially fatal occupational diseases characterized by respiratory dysfunction, chronic interstitial inflammation, and fibrosis, for which treatment options are limited. Previous studies showed that a novel N-arylpyridone compound named AKEX0011 exhibited anti-inflammatory and anti-fibrotic effects in bleomycin-induced pulmonary fibrosis; however, it is unknown whether it could also be effective against silicosis. Therefore, we sought to investigate the preventive and therapeutic roles of AKEX0011 in a silicosis rodent model and in a silica-stimulated macrophage cell line. In vivo, our results showed that AKEX0011 ameliorated silica-induced imaging lung damages, respiratory dysfunction, reduced the secretion of inflammatory and fibrotic factors (TNF-α, IL-1β, IL-6, TGF-β, IL-4, and IL-10), and the deposition of fibrosis-related proteins (collagen I, fibronectin, and α-SMA), regardless of early or advanced therapy. Specifically, we found that AKEX0011 attenuated silicosis by inhibiting apoptosis, blocking the ASK1-p38 MAPK signaling pathway, and regulating polarization of macrophages. In vitro, AKEX0011 inhibited macrophages from secreting inflammatory cytokines and inhibited apoptosis of macrophages in pre-treated and post-treated models, concurrent with blocking the ASK1-p38 pathway and inhibiting M1 polarization. Collectively, AKEX0011, as a novel N-arylpyridone compound, exerted protective effects for silica-induced pulmonary inflammation and fibrosis both in vivo and in vitro, and hence, it could be a strong drug candidate for the treatment of silicosis. Frontiers Media S.A. 2022-03-23 /pmc/articles/PMC8983992/ /pubmed/35401236 http://dx.doi.org/10.3389/fphar.2022.848435 Text en Copyright © 2022 Fan, Xiao, Song, Zhu, Zhang, Zhang, Wang, Dai and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fan, Mingming
Xiao, Huijuan
Song, Dingyun
Zhu, Lili
Zhang, Jie
Zhang, Xinran
Wang, Jing
Dai, Huaping
Wang, Chen
A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title_full A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title_fullStr A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title_full_unstemmed A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title_short A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization
title_sort novel n-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ask1-p38 pathway and regulating macrophage polarization
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983992/
https://www.ncbi.nlm.nih.gov/pubmed/35401236
http://dx.doi.org/10.3389/fphar.2022.848435
work_keys_str_mv AT fanmingming anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT xiaohuijuan anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT songdingyun anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhulili anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangjie anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangxinran anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangjing anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT daihuaping anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangchen anovelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT fanmingming novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT xiaohuijuan novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT songdingyun novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhulili novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangjie novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT zhangxinran novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangjing novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT daihuaping novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization
AT wangchen novelnarylpyridonecompoundalleviatestheinflammatoryandfibroticreactionofsilicosisbyinhibitingtheask1p38pathwayandregulatingmacrophagepolarization